Gene: LRRC25
Official Full Name: leucine rich repeat containing 25provided by HGNC
Gene Summary: Predicted to act upstream of or within several processes, including canonical NF-kappaB signal transduction; connective tissue replacement involved in inflammatory response wound healing; and response to angiotensin. Located in cytosol; endoplasmic reticulum; and microtubule cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA05239 | LRRC25 Knockout cell line (AC16) | Human | LRRC25 | 1:3-1:4 | negative | Online Inquiry |
| KOA20685 | LRRC25 Knockout cell line (BEAS-2B) | Human | LRRC25 | 1:3~1:4 | negative | Online Inquiry |
| KOA36129 | LRRC25 Knockout cell line (U-2932) | Human | LRRC25 | 1:2-1:4 | negative | Online Inquiry |
| KOA51539 | LRRC25 Knockout cell line (TPC-1) | Human | LRRC25 | 1:5-1:8 | negative | Online Inquiry |
| KOA66944 | LRRC25 Knockout cell line (NCM460) | Human | LRRC25 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.